DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features:The RCRP encourages applicants to in
- Funding
- Estimated total program funding: $7,350,000
- Deadline
- November 19, 2026
- Status
- OPEN
- Category
- Research & Science
- Opens
- June 17, 2026
- Directory link check
- October 27, 2026
About this opportunity
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features:The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should have high potential impact on rare cancers and the patient community.
Eligibility recorded
No sufficiently specific eligibility summary is stored. Read the official notice before deciding whether you qualify.